How is it that pharma companies—and, by extension, health insurers that cover drugs—have targets on their backs while hospitals live like wallflowers?

Much like the agreement the agency made with Express Scripts, CVS Health’s Caremark will be required to recognize purchases made through TrumpRx, the federal government’s direct-to-consumer pharmaceutical marketplace.

In theory, GLP-1 receptor agonist drugs like semaglutide and tirzepatide should save a lot of money for the health insurers that pay for them. As it turns out, the lived reality is not keeping pace with the idealistic expectation. 

The Trump administration said the reduction can be attributed to a cleanup of fraud, waste and abuse, but the real reason extends back to enhanced subsidies put in place during the COVID-19 pandemic.

On the very bottom stands Maryland. The report from WalletHub looked at the median income of households in each state, analyzing what percentage of household income a silver plan consumes.